
    
      Between November 2010 and April 2012, 2164 consecutive patients who agreed to attend the
      randomized control study were enrolled. All the participants received surgery for thyroid and
      parathyroid disease at Ito Hospital and randomized in three groups; Group A (n=541):
      operation with AMP (PIPC, piperacillin sodium), Group B (n=541): operation with AMP (CEZ,
      cefazolin sodium), and Group C (n=1082): operation without AMP.

      Exclusion criteria

        -  Patients who did not agree to attend the randomized control study.

        -  Patients who received the operation including mediastinum with sternotomy.

        -  Patients who received the operation including additional resection of trachea, esophagus
           and larynx.

        -  Patients who received the re-operation for post-operative bleedings.

        -  Patients who had known allergy to cephem or penicillin.
    
  